Avoiding Anticoagulation After IntraCerebral Haemorrhage (A3ICH)
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
A PHASE3 clinical study on Atrial Fibrillation and Intracerebral Hemorrhage, this trial is actively recruiting participants. The trial is conducted by Institut National de la Santé Et de la Recherche Médicale, France and has accumulated 9 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Mar 2025 — Present [monthly]
Recruiting PHASE3
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Feb 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2023 [monthly]
Recruiting PHASE3
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Mar 2019 — Sep 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut National de la Santé Et de la Recherche Médicale, France
- Ministry of Health, France
- University Hospital, Lille
For direct contact, visit the study record on ClinicalTrials.gov .